• Didcot
• Competitive + Bonus + Stocks
• Posted 12 days ago

About the company   A spin out of one of the most prestigious vaccine research institutes in the world, this Oxford-based immunotherapy biotech is on the brink of entering Phase 3 clinical trials.   With operations across two continents, they are committed to remaining an independent company and ...